Edition:
United States

Medigus Ltd (MDGS.OQ)

MDGS.OQ on NASDAQ Stock Exchange Capital Market

1.43USD
11 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.43
Open
$1.45
Day's High
$1.46
Day's Low
$1.42
Volume
6,120
Avg. Vol
10,906
52-wk High
$10.60
52-wk Low
$1.41

Summary

Name Age Since Current Position

Nissim Darvish

Chairman of the Board

Christopher Rowland

54 2016 Chief Executive Officer, Vice President of Sales and Marketing, Director

Oded Yatzkan

50 2017 Chief Financial Officer, Director

Minelu Sonnenschein

51 2014 Vice President - Operations

Yaron Zilberman

43 2011 Vice President - Sales and Marketing

Tatyana Yossef

30 2009 Controller

Aviel Shapira

62 2000 Chief Medical Officer

Doron Birger

66 2015 Director

Erez Haimovitz

Director

Anat Naschitz

Director

Yair Rabinowitch

72 2013 Director

Efrat Venkert

47 2013 External Director

Eitan Machover

55 2016 Independent Director

Biographies

Name Description

Nissim Darvish

Dr. Nissim Darvish serves as Chairman of the Board of Medigus Ltd. Dr. Darvish is a Senior Managing Director at OrbiMed. Dr. Davish is a veteran of the life science industry, with 15 years of experience covering medical technology development, corporate leadership and investment management. Dr. Darvish spent eight years with Pitango, where he was a General Partner managing life sciences investments. Previously, Dr. Darvish was the founder and CEO of Impulse Dynamics, which he led for six years. Dr. Darvish obtained his M.D. and Ph.D. in Biophysics and Physiology from the Technion in Israel, and subsequently conducted his postdoctoral research at the NIH. He has published over 100 patents, authored over 20 publications and received eight prizes and awards.

Christopher Rowland

Mr. Christopher Rowland has been appointed Vice President of Sales and Marketing at Medigus Ltd, in addition to his current roles of Chief Executive Officer and Director at the Company, effective December 31, 2016. He has held the roles of Chief Executive Officer and Director since October 1, 2013. Previously, he served as Chief Executive Officer at Intrapace Inc, and NeoTract Inc, and President - Americas at Given Imaging Inc. Mr. Rowland holds a Bachelors degree in Marketing from Southern Illinois University.

Oded Yatzkan

Mr. Oded Yatzkan has been appointed Chief Financial Officer and Director at Medigus Ltd effective January 31, 2017. Until this date he will continue to serves as Vice President - Finance and Accounting and Director at the Company, as he has since August 1, 2015. Prior to these roles, he served as Chief Financial Officer at the Company from September 1, 2003. He holds a Bachelors degree in Economics and a MBA degree, both from Ben Gurion University.

Minelu Sonnenschein

Dr. Minelu Menashe Sonnenschein has been appointed Vice President - Operations Israel at Medigus Ltd. effective June 1, 2014. Prior to this role, He served as Vice President - Research & Development at the Company from January 1, 2000. Dr. Sonnenschein holds a BSc degree and a Doctorate of Science degree in Electrical and Electronics Engineering, both from Ben Gurion University.

Yaron Zilberman

Tatyana Yossef

Ms. Tatyana Yossef has served as Controller of Medigus Ltd since December 1, 2009. Previously, she was Auditor with PricewaterHouseCoopers Israel, and with Somech, Cheikin & Assoc. Ms. Yossef received her Bachelors degree in Accounting and Economics from Ben-Gurion University of the Negev. She is Certified Public Accountant.

Aviel Shapira

Doron Birger

Mr. Doron Birger has been appointed Director at Medigus Ltd effective May 17, 2015. His work experience includes the following roles: Chairman of the Board at 5 private Companies from 2009, Consultant from 2009 and Manager Landmark Ventures (Israel) between 2010 and 2013. He holds Bachelor of Arts degree and a Master of Arts degree, both from The Hebrew University of Jerusalem.

Erez Haimovitz

Anat Naschitz

Ms. Anat Naschitz serves as Director at Medigus Ltd. She is a Managing Director at OrbiMed. She has over 17 years of healthcare experience. Ms. Naschitz spent seven years with McKinsey & Company in London, where she was an Associate Partner, managing strategy and M&A projects for senior management of the pharmaceutical and biotechnology companies. Among other accomplishments, Ms. Naschitz led pharmaceutical spinout work resulting in the creation of two European biotech companies. Ms. Naschitz then joined Apax Partners, where she focused on life sciences investments. Subsequently, Ms. Naschitz served as a director/advisor to the boards of life science companies and investors. She earned her MBA at INSEAD and her LLB at Tel Aviv University.

Yair Rabinowitch

Efrat Venkert

Ms. Efrat Venkert has served as External Director of Medigus Ltd since September 29, 2013. She is an attorney and licensed mediator. Prior to joing Medigus Ltd, she ran her own Law Office. Ms. Venkert received her Bachelors degree in Law from The Hebrew University of Jerusalem, and her Masters degree in Business Administration from The University of Haifa.

Eitan Machover

Mr. Eitan Machover has been appointed as Independent Director of the Company., effective September 29, 2016. Mr. Machover has more than 30 years of leadership experience in healthcare, having held various business development and M&A positions at GE Capital in the U.S., Europe and Asia. He headed business development activities at GE Healthcare in Europe, where he oversaw large-scale acquisitions. In addition, he led integrations into GE's Israeli operations and was later named the National Executive for General Electric Israel, overseeing all of GE's activities in the country. Since then, Mr. Machover co-established MediTech Advisors, where he managed two U.S. based medical device venture funds, and also served as CEO of Wellsense, Inc. a U.S. medical device company. Currently, he is the principal and owner of EM Advisory Service, Ltd. an Israel-based executive search firm. Mr. Machover holds a BS in Business Communications from Emerson College and an MBA from Boston College.